IFNg is critical for host defence against various food-borne pathogens including Salmonella enterica and Listeria monocytogenes, the causative agents of salmonellosis and listeriosis, respectively. We investigated the impact of regional IFNg expression at the intestinal epithelial barrier on host invasion by salmonellae and listeriae following oral challenge. Transgenic mice (IFNg-gut), generated on an IFNg knock-out (KO) background, selectively expressed IFNg in the gut driven by the modified liver fatty acid-binding protein (Fabpl 43 at 2132 ) promoter. Infections with attenuated S. enterica Typhimurium or with L. monocytogenes did not differ significantly in IFNg-KO, IFNg-gut and wild-type mice. Further, Listeria-specific CD4 1 and CD8 1 T cells were not altered in IFNg-gut mice. Thus, this model indicates that local IFNg expression by non-immunological cells in the distal part of the small intestine, caecum and colon is insufficient for prevention of gut penetration by S. enterica Typhimurium and L. monocytogenes.
Introduction
Salmonella enterica and Listeria monocytogenes are intracellular bacterial pathogens, which enter the host through the gut epithelial barrier during natural infection (1, 2) . Hence, the intestinal epithelium provides a first line of defence against these food-borne pathogens. Once these pathogens have successfully penetrated the epithelium, they rapidly spread to other tissue sites. Following oral infection, salmonellae replicate in mucosa-associated lymphoid tissues such as the Peyer's patches (PP) and subsequently disseminate via the mesenteric lymph nodes (MLNs) (3) . Listeriae and salmonellae, in addition to invading the host via PP in the small intestine and disseminating via MLN, can enter through the colon (4) or via CD18-expressing phagocytes (5), respectively. Listeriae that enter through the colon subsequently spread via the caudal lymph node (CLN) (4, 6) . Innate immune defence against infectious agents is mediated by various cytokines, which interact in a highly regulated network (7, 8) . The importance of IFNc in intestinal host defence against S. enterica Typhimurium and L. monocytogenes has been extensively documented (3, (9) (10) (11) (12) (13) (14) (15) (16) . This is true both for systemic and regional defence. Previous studies identified elevated levels of IFNc mRNA in gutassociated lymphoid tissue after challenge with S. enterica Typhimurium (15) . In PP, IFNc mRNA was detected at 6 h, in MLN at 24 h and in spleen at 4 days after challenge. Administration of neutralizing mAbs to IFNc completely abrogates resistance to oral challenge with salmonellae and listeriae (9, 15) and susceptibility to systemic infection is greatly enhanced (17) . IFNc is produced by both activated T cells and NK cells during host defence against these pathogens (7, 16) . In addition, impaired host intestinal immunity in IFNc-deficient mice following S. enterica Typhimurium or L. monocytogenes oral challenge has been demonstrated (3, 18, 19) .
We generated IFNc transgenic mice, which exclusively produce IFNc in the gut on a general IFNc knock-out (KO) background (IFNc-gut) to directly examine the role of regional IFNc production in the intestinal epithelium against the intracellular pathogens S. enterica Typhimurium and L. monocytogenes. The expression of IFNc is driven by the modified liver fatty acid-binding protein (Fabpl 43 at À132 ) promoter that exhibits gut-specific expression with increasing activity from the proximal to the distal part of the small intestine as well as in the caecum and colon (20) . A low level of expression in the kidney was also reported (20) . The IFNcgut mice were orally infected with S. enterica Typhimurium, strain SL7207, which is deficient in aroA or with L. monocytogenes strain EGD, and penetration of the intestinal epithelial barrier by these pathogens was analysed. Moreover, we characterized T cell responses in the different mouse strains following infection with L. monocytogenes. Our experiments reveal that despite similar pathogen-specific CD4 + and CD8 + T cell responses in IFNc-gut mice, regional IFNc expression by epithelial cells is insufficient for efficacious control of infection.
Methods

Generation of IFNc-gut mice
The Fabpl 43 at À132 promoter was cleaved from a recombinant plasmid (kind gift from J. Gordon, St Louis, Missouri, USA) using EcoRI and BamHI restriction enzymes. A 469-bp IFNc cDNA fragment was PCR amplified from a recombinant plasmid containing the full-length IFNc cDNA with oligonucleotides containing BamHI and XbaI restriction sites. The 5#-end primer was 5#-CGGGATCCATGAACGCTACA-CACTGCATC-3# and the 3#-end primer was 5#-GCTCTAGAT-CAGCAGCGACTCCTTTTCCGC-3#. The resulting PCR product was cleaved with BamHI and XbaI at the 5#-and 3#-ends, respectively. The SV40 small t-intron/polyadenylation sequence was PCR amplified from the vector pGL2-Basic (Promega, Madison, WI, USA) with oligonucleotides containing restriction sites that enabled the resulting product to be cleaved with XbaI and NotI at the 5#-and 3#-ends, respectively. The Fabpl 43 at À132 promoter, the IFNc cDNA and the SV40 small t-intron/polyadenylation sequence were cloned into pBluescript in that order. Transient transfections using lipofectin (Invitrogen, Carlsbad, CA, USA) with this recombinant plasmid into 293T cells were performed according to the manufacturer's protocol and supernatants removed and concentrated 4-fold using AMICON (10 000 kDa cut-off) spin columns. IFNc in supernatants was detected by ELISA using mAb R4-6A2 to capture the IFNc and mAb XMG1.2 biotin labelled followed by streptavidin conjugated with peroxidase to detect the captured IFNc. To generate the IFNc-gut mice, the complete construct was cleaved out of the vector with EcoRI and NotI, gel purified and used for pro-nuclear injection of oocytes from an IFNc-KO mouse on a C57Bl/6 background (kind gift from T. Stewart, South San Francisco, CA, USA).
RNA isolation and quantitative PCR
Mice were sacrificed before or after Salmonella or Listeria infection (see below). RNA from tissue samples (2 cm intestinal sections and ;50 mg from other organs) was isolated with TRIzol (Invitrogen) using the FastRNA tubes green (Q-Biogene, Irvine, CA, USA) and subjected to DNAse I treatment according to their protocol. Quantity and quality of isolated RNA were determined by the Bioanalyser and by OD measurement. Reverse transcription was performed with random primers using the Superscript reverse transcription kit from Invitrogen. Quantitative PCR was performed with SyBR Green mix (Applied Biosystems, Foster City, CA, USA) using the Applied Biosystems machine. The real-time PCR mixture was prepared as follows: 15 ll SyBR Green mix, 0.15 ll of a 100 pm solution each of forward and reverse primer and 5 ll of a 1:15 diluted cDNA synthesized according to the reverse transcription kit. Each sample for real-time PCR was made in triplicate and mean of the resulting three values were taken. The following primers for IFNc, IFNcinducible protein-10 (IP10) and IFN-inducible GTPase (IIGP) amplifications were used: IFNc forward 5#-ACGGCACAGT-CATTGAAAGCCTA-3# and reverse 5#-GTCACCATCCTTTT-GCCAGTTCC-3#, IP10 forward 5#-CCGTCATTTTCTGCCTC-ATCCT-3# and reverse 5#-GCTTCCCTATGGCCCTCATTCT-3# and IIGP forward 5#-GCCACCAATCTTCCTGCTCTCTAAC-3# and reverse 5#-CTTCCAGCCAAATCCTCTGCTTC-3#.
Histology
Macroscopic and microscopic examination of histopathology (inflammation) was performed in situ and in formalin-fixed intestinal tissue, respectively. Microscopical analysis was performed in a blind fashion for signs of infiltration, ulceration, mucosal thickening, haemorrhage and epithelial cell integrity.
Oral infections with salmonellae and listeriae
A frozen aliquot of deficient (aroA -) S. enterica Typhimurium (SL7207) or wild-type (wt) S. enterica Typhimurium (SL1344) was inoculated in 100 ml of Luria-Bertani (LB) medium containing 0.3 M NaCl and left overnight in a 37°C incubator. A frozen aliquot of L. monocytogenes strain EGD was inoculated in 100 ml tryptic soy broth and incubated at 37°C overnight with gentle shaking at 90 r.p.m. Bacterial cultures were harvested by centrifugation at 3000 3 g for 10 min in 50 ml Falcon tubes and washed twice in PBS. After OD 600 measurement, they were diluted with PBS from 0.5 3 10 9 to 1.5 3 10 10 colony-forming units (CFU) per ml (taking OD 600 as 10 9 CFU) and 200 ll was used for intragastric gavage. CFU were always controlled by plating of serial dilutions of the inoculum. To determine bacterial burdens, mice were sacrificed after 1 or 2 days, spleen and MLNs homogenized in PBS and serial dilutions of homogenates were plated on LB agar plates. Colonies were counted after overnight incubation at 37°C.
Purification of cells and intracellular cytokine staining
Lymphocytes from spleen, MLNs, small intestine epithelium and small intestine lamina propria were isolated as previously described (21, 22) . Cells (1 3 10 6 -4 3 10 6 ) were cultured in a 1-ml volume of RPMI 1640 medium supplemented with glutamine, Na-pyruvate, b-mercaptoethanol, penicillin, streptomycin and 10% heat-inactivated FCS. Cells were stimulated for 5 h with 10 À6 M of the peptides listeriolysin O amino acids [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] , NEKYAQAYPNVS) or ovalbumin 257-264 (OVA 257-264 , SIINFEKL). During the final 4 h of culture, 10 lg ml À1 brefeldin A (Sigma Aldrich, Taufkirchen, Germany) was added. Cultured cells were washed and incubated for 10 min with rat serum and anti-CD16/CD32 mAb to block non-specific antibody binding. Subsequently, cells were either stained with PE-conjugated anti-CD4 mAb or PE-Cy7-conjugated anti-CD8a mAb, and after 30 min on ice, cells were washed with PBS and fixed for 20 min at room temperature with PBS 4% PFA. Cells were washed with PBS and 0.1% BSA, permeabilized with PBS, 0.1% BSA and 0.5% saponin (Sigma) and incubated in this buffer with rat serum and anti-CD16/CD32 mAb. After 5 min, Cy5-conjugated anti-tumour necrosis factor a (TNFa) mAb was added. After a further 20 min at room temperature, cells were washed with PBS and fixed with PBS 1% PFA. Cells were analysed using a FACS Canto and DIVA software (Becton-Dickinson, Mountain View, CA, USA).
Antibodies
Anti-CD16/CD32 mAb (clone: 2.4G2) and anti-TNFa mAb (XT22) were purified from rat serum or hybridoma supernatants with protein G sepharose. Antibodies were Cy5-conjugated according to the standard protocols. PE-conjugated anti-CD4 mAb (GK1.5) and PE-Cy7-conjugated anti-CD8a mAb (53-6.7) were purchased from BD PharMingen (San Diego, CA, USA).
Infection of mice for determination of T cell responses
C57Bl/6 mice were bred in our facility and experiments were conducted according to the German animal protection laws. All mice were infected with a recombinant Listeria monocytogenes strain-expressing ovalbumin (23), termed LmOVA. Mice were infected with 2 3 10 9 LmOVA by gastric incubation and were analysed on day 9 post-infection (p.i.).
Results
IFNc expression driven by the modified Fabpl promoter, Fabpl 43 at À132
The transgenic construct contained mouse IFNc cDNA downstream of the Fabpl 43 at À132 promoter. To avoid any endogenous post-transcriptional regulatory sequences in the IFNc mRNA, the cloned 469-bp IFNc cDNA contained only the sequence from the AUG start codon to the UGA stop codon. 293T kidney cells were transfected with the transgenic construct and production of IFNc was determined. In the supernatant of transfected 293T kidney cells, but not of control cells, IFNc was detected by ELISA (data not shown) indicating that the construct was functional.
Gut-specific and functional IFNc expression in transgenic mice
The IFNc-gut mice were generated on an IFNc-KO background. In IFNc-gut mice, the IFNc cDNA signal was detected and mice were deficient for the endogenous IFNc gene as determined by the PCR on DNA isolated from tail clips (data not shown). Compared with wt mice, the transgenic mice expressed IFNc in the distal part of the small intestine at levels similar to wt mice and expression increased towards the caecum with a maximum level of expression in the colon. Quantitative PCR analysis (Table 1) revealed that IFNc expression was elevated 19-fold in the caecum and 44-fold in the colon relative to IFNc expression levels in wt mice. We analysed RNA levels of the IFNc-responsive genes IP10 and IIGP to verify whether the transgene-encoded IFNc was functionally active. Compared with wt mice, IP10 mRNA expression in IFNc-gut mice was 2.5-fold and 5.3-fold higher in caecum and colon, respectively. IIGP RNA was 8-fold and 13-fold higher in IFNc-gut caecum and colon, respectively (Table 1) . There was an increase in IFNc expression levels in wt caecum and colon, 48 h p.i. with S. enterica Typhimurium aroA À , as the IFNc levels in both caecum and colon in IFNc-gut mice were only ;9-and 8-fold higher, respectively, compared with wt mice (Table 1) . Levels of IFNcresponsive genes, IP10 and IIGP, were also up-regulated. IP10 levels were higher in caecum and colon of infected wt mice; in IFNc-gut mice, levels were only À1.25-fold and +1.15-fold different while they were 2.54-fold and 5.35-fold higher when compared with naive wt mice. (A negative value such as À1.25-fold in IFNc-gut mice versus infected wt mice indicates it is 1.25-fold greater in infected wt compared with IFNc-gut mice.) Similarly, IIGP levels were only 3.6-fold and 2.3-fold higher in caecum and colon of IFNc-gut mice compared with infected wt mice while these were 8-fold and 13-fold higher when compared with naive wt mice. As ELISA on systemic compartments such as the MLNs, liver and spleen did not reveal the presence of IFNc protein (data not shown). Similarly, we did not detect any IFNc in systemic compartments or in serum of IFNc-gut mice on western blots with antibodies against IFNc although they did bind to recombinant IFNc that was used as a positive control (data not shown).
Histological examination of the gut
IFNc-gut mice did not show any signs of infiltration, ulceration, mucosal thickening, haemorrhage or epithelial cell integrity (data not shown). Therefore, compared with the wt mice, IFNc-gut mice were free of apparent signs of pathology indicating that the levels of IFNc produced regionally in the IFNc-gut mice did not lead to chronic inflammation.
Oral infection with attenuated S. enterica Typhimurium
IFNc-gut, IFNc-KO and wt mice were orally infected with the wt, fully virulent S. enterica Typhimurium strain SL1344 (Fig. 1A) and CFU in spleen and MLN were determined. Using this strain, we observed similar CFU in MLNs and spleens of IFNc-KO and IFNc-gut mice. Once past the intestinal barrier, S. enterica Typhimurium rapidly multiplies, especially in the absence of IFNc, making it difficult to determine any major difference in the CFU between wt, IFNc-KO and IFNc-gut mice. Therefore, mice were orally infected with the attenuated aroA À S. enterica Typhimurium strain SL7207, which shows reduced growth in vivo. Figure 1(B) demonstrates that after SL7207 infection, the range of CFU in MLNs and spleens of IFNc-gut mice was similar to that in IFNc-KO mice, as well. Thus, regional IFNc expression in the distal part of the small intestine, caecum and colon was insufficient to control penetration of the gut epithelial barrier by salmonellae through uptake by PP, at least at the IFNc abundance produced by IFNc-gut mice. 
Oral infection with L. monocytogenes
IFNc-gut, IFNc-KO and wt mice were orally infected with L. monocytogenes, and CFU in MLN and spleen were determined (Fig. 1C) . Similar to S. enterica Typhimurium infection, listerial CFU in the MLN did not show significant differences among the three groups although CFU in MLN of wt mice were lower than those in IFNc-KO mice. Hardly any CFU were detected in spleen suggesting the absence of significant injury during intragastric gavage. As with spleens, we observed increased CFU in the liver after 48 h (data not shown). This was probably due to invasion and multiplication of bacteria rather than due to injury during intragastric gavage since in the latter case we would have already observed increased CFU after 24 h. Since the colon of IFNc-gut mice expressed 44-fold more IFNc compared with wt mice, and as the colon is drained through the CLN, CFU in CLN were determined after oral infection with L. monocytogenes. No significant differences were observed among the different groups of mice (data not shown). This may also be due to a narrow temporal window before listeriae invade the CLN.
Antigen-specific T cell responses in intestinal tissues
To determine whether local IFNc expression in the gut affects antigen-specific CD4 + and CD8 + T cell responses, IFNc-gut, IFNc-KO and wt mice were orally infected with 2 3 10 9 CFU LmOVA. Bacteria were cleared by antibiotics at day 3 p.i. and LLO 190-201 -specific CD4
+ and OVA 257-264 -specific CD8
+ T cell responses were measured at day 9 p.i. in spleen, MLN and in the intraepithelial lymphocytes and LPL compartment (21, 22 + T cell responses (Fig. 2) . In contrast to wt mice, OVA-specific T cell responses were slightly increased in IFNc-gut and in IFNc-KO mice. This could be explained by the increased antigenic load in INFcgut mice due to initially elevated bacterial titres or by the regulatory function of IFNc, as recently described (24) .
Discussion
The data presented suggest that exclusive IFNc production in the gut is insufficient for control of penetration of the gut epithelial barrier by food-borne bacterial pathogens such as S. enterica Typhimurium and L. monocytogenes. Host invasion by listeriae after oral infection proceeds via the gastrointestinal tract (4) . Because colon and rectum are drained by CLN (4), dissemination and subsequent systemic infection involve CLN. Penetration of the small intestine involves uptake by PP from where listeriae spread via the lymph to the spleen and liver. Salmonellae, on the other hand, penetrate the gut epithelial barrier mainly through the PP in the small intestine. General failure to produce IFNc increases susceptibility of mice to bacterial infection (3). Thus, evidence has been presented that IFNc produced in the intestine plays a role in regional host defence against food-borne bacterial pathogens (3, 15) . In this study, we aimed at determining the impact of gut-specific IFNc expression on regional host defence against food-borne bacterial infection. To achieve this goal, we created IFNc-gut transgenic mice on an IFNc-KO background, selectively expressing IFNc in the small intestine, caecum and colon.
The IFNc-gut mice expressed an increasing gradient of IFNc from the distal region of the small intestine to the colon (see Table 1 ). In the distal part of the small intestine, the amount of IFNc mRNA was comparable to naive wt controls and towards the proximal region it was lower than in wt mice. IFNc-gut caecum and colon had 19-fold and 44-fold more IFNc mRNA, respectively, relative to wt mice. These levels are not reached during an oral infection of wt mice with S. enterica Typhimurium aroA À . This became apparent when comparing caecum and colon of IFNc-gut mice relative to infected wt mice, where the levels of IFNc-gut were only 9-fold to 8-fold higher. The IFNc-responsive genes, IP10 and IIGP, also followed this pattern in the caecum and colon, i.e. higher IFNc expression resulted in more IP10 and IIGP mRNA expression, demonstrating that the IFNc expressed in IFNc-gut mice was functional. In addition, minute expression was found in the kidney but none in liver and stomach (data not shown) as expected from the Fabpl 43 at À132 promoter expression pattern. This promoter was reported to drive expression in goblet, enteroendocrine, and Paneth cells throughout the duodenal-ileal axis and in colon that lacks Paneth cells (20) .
Our data reveal that regional IFNc production in the intestine (at least at the moderate levels in the small intestine with an increasing gradient towards the colon, produced in the IFNc-gut mice described here) is insufficient for control of the spread of salmonellae and listeriae from the gut to the MLN. Because salmonellae penetrate the gut epithelial barrier mainly through uptake by PP, this gradient of IFNc expression may explain the lower Salmonella burden in MLN of IFNc-gut mice as compared with IFNc-KO mice and higher Salmonella burden compared with wt mice. We assume that in the proximal part of the small intestine, little or virtually no IFNc is produced to activate antibacterial capacities in macrophages. In this region, salmonellae can penetrate the epithelium through PP. Towards the distal region of the small intestine, IFNc expression increased and could partly contribute to control of the salmonellae resulting in lower CFU in MLN. Although in IFNc-gut mice IFNc was not expressed in PP, we cannot exclude that IFNc may have diffused into the PP and stimulated immune cells. However, in contrast to the extent of control of salmonellae seen in wt mice, lack of sufficient control of salmonellae in IFNc-gut mice suggests that the amount of IFNc produced by gut epithelial cells that may have entered the PP was too low to compensate for lack of IFNc production by immune cells in PP. Another possibility is that the immune response mounted against salmonellae in the distal part of the small intestine in IFNc-gut mice was more efficacious due to IFNc expression whereas in the proximal part and in the other parts of the small intestine, immunity was weak or absent. This could explain apparent lack of an effective immune response in MLN of IFNc-gut mice. Thus, in spite of local IFNc expression, no significant differences were observed between IFNc-gut and IFNc-KO mice in host defence against oral Salmonella and Listeria infections, although after oral Salmonella infection the CFU in MLN of IFNc-gut mice were lower than those in IFNc-KO mice. As expected, wt mice showed lower CFU in MLN compared with IFNc-KO mice when infected with either salmonellae or listeriae.
It could be argued that the IFNc concentration in IFNc-gut mice was below the required threshold levels for macrophage activation. However, real-time PCR data suggest that the lowest levels of IFNc that were detected in the distal part of the small intestine in IFNc-gut mice were similar to IFNc concentrations measured in naive wt mice and increased up to 44-fold, relative to wt mice, in the colon. Yet, CFU in IFNc-gut mice were consistently higher than those in the caecum and colon of wt mice. Given that regional IFNc expression in the gut was sufficient for control at the gut barrier, the CFU in MLN of IFNc-gut mice should have been significantly less than CFU in MLN of IFNc-KO mice, at least with listeriae, which can penetrate the gut epithelial barrier through PP-independent mechanisms.
There is some controversy as to which immune cells produce IFNc during bacterial infection. NK cells, T cells, DCs and macrophages are thought to be major producers of IFNc although it has been reported that IFNc produced by macrophages and DCs rather than by NK cells and T cells primarily contributes to control of listerial infections, after intra-peritoneal administration (16) . In any case, our results imply that immune cells, rather than gut epithelial cells, represent the crucial source of IFNc in defence against food-borne bacterial infections Because NK cells, T cells, DCs and macrophages in IFNcgut mice do not produce IFNc (due to the general IFNc deficiency), we assume that IFNc production by these immune cells is essential for effective antibacterial defence against salmonellae and listeriae at the gut barrier in normal mice. In these mice, IFNc produced by NK cells and T cells during infection probably stimulates additional IFNc secretion in antigen-presenting cells namely macrophages and DCs (16) . This could ultimately cause efficient activation of antibacterial capacities in macrophages. This feedback loop is interrupted in IFNc-gut and IFNc-KO mice because of general IFNc deficiency. It has to be noted that LLO 190-201 -specific CD4 + and OVA 257-264 -specific CD8 + T cell functions were not impaired in both mutant mouse strains. In contrast, as a consequence of the reduced anti-microbial capacity of IFNc mutant mice, the increased antigenic load in these mice may explain slightly enhanced frequencies of antigenspecific CD4
+ and CD8 + T cells as compared with wt mice. In conclusion, our experiments suggest that regional IFNc expression by non-immunological cells at the gut barrier is insufficient for regional defence against food-borne infection with S. enterica and L. monocytogenes. On the other hand, in wt mice, IFNc clearly plays a central role in the defence against these pathogens and it is possible that increasing the amount of regional IFNc expression in the gut improves control of bacterial infections at the gut barrier. Such constitutively produced high IFNc levels, however, could favour the development of chronic inflammation (25 
